EUVIMEDEUVIMED entdecken
Open Access

Multimorbidity in Atrial Fibrillation: Impact on Outcomes

Sheila M Manemann, Alvaro Alonso iD, Peter A Noseworthy iD, Konstantinos C Siontis iD, Bernard J Gersh iD, Véronique L Roger iD, Euijung Ryu, Jill M Killian iD, Susan A Weston, Lisa E Vaughan iD, Alanna M Chamberlain iD

Journal of the American Heart Association · 2026

DOI: 10.1161/jaha.124.040612 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, 2026. Verfasst von Sheila M Manemann und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Quantitative Health Sciences Mayo Clinic Rochester MN USA. Hauptthemen laut MEDLINE: Atrial Fibrillation, Heart Failure. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Multimorbidity is common in patients with atrial fibrillation (AF); however, the impact of the number and type of comorbid conditions on outcomes remains uncertain.

Methods

This cohort study included patients with new‐onset AF from a Midwest region between 2013 and 2017. Eighteen chronic conditions at the time of AF were classified into groups: cardiometabolic, other somatic, and mental health. Cox regression determined associations between the number of each condition type with death, ischemic stroke/transient ischemic attack, and congestive heart failure, stratified by age.

Results

Among 16 509 patients with AF (mean age, 74 years; 43% women), the mean number of cardiometabolic, other somatic, and mental health conditions was 2.7, 1.4, and 0.5, respectively. The number and type of conditions had a varying impact on outcomes and differed by age. A higher number of cardiometabolic conditions were associated with increased risk of death within 90 days only in people aged ≥85 years (≥4 conditions versus 0: hazard ratio [HR], 1.74 [95% CI, 1.05–2.87]), whereas for death after 90 days, associations were strongest in the youngest age group (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationHeart FailureHumansFemaleAgedMultimorbidityMaleAged, 80 and overRisk FactorsMiddle AgedAge FactorsRisk AssessmentPrognosisIschemic Attack, Transient

Stichwörter der Autor:innen

atrial fibrillationchronic conditionsmultimorbidityoutcomes

Autor:innen und Institutionen

  • Department of Quantitative Health Sciences Mayo Clinic Rochester MN USA.
  • Department of Epidemiology, Rollins School of Public Health Emory University Atlanta GA USA.
  • Department of Cardiovascular Medicine Mayo Clinic Rochester MN USA.
  • Epidemiology and Community Health Branch, National Heart, Lung, and Blood Institute National Institutes of Health Bethesda MD USA.

ORCID-Profile: Alvaro Alonso, Peter A Noseworthy, Konstantinos C Siontis, Bernard J Gersh, Véronique L Roger, Jill M Killian, Lisa E Vaughan, Alanna M Chamberlain

Zitieren

APA

Manemann, S. M., Alonso, A., Noseworthy, P. A., Siontis, K. C., Gersh, B. J., Roger, V. L., Ryu, E., Killian, J. M., Weston, S. A., Vaughan, L. E., & Chamberlain, A. M. (2026). Multimorbidity in Atrial Fibrillation: Impact on Outcomes. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.040612

Vancouver

Manemann SM, Alonso A, Noseworthy PA, Siontis KC, Gersh BJ, Roger VL, et al. Multimorbidity in Atrial Fibrillation: Impact on Outcomes. Journal of the American Heart Association. 2026. doi:10.1161/jaha.124.040612

BibTeX
@article{Manemann2026,
  author = {Manemann, Sheila M and Alonso, Alvaro and Noseworthy, Peter A and Siontis, Konstantinos C and Gersh, Bernard J and Roger, Véronique L and Ryu, Euijung and Killian, Jill M and Weston, Susan A and Vaughan, Lisa E and Chamberlain, Alanna M},
  title = {Multimorbidity in Atrial Fibrillation: Impact on Outcomes},
  journal = {Journal of the American Heart Association},
  year = {2026},
  doi = {10.1161/jaha.124.040612}
}
Kostenlos starten →